Скачать или смотреть Challenges in Clinical Trial Design

CHILDHOOD CANCER HEARING LOSS

AN EXTERNALLY-LED PATIENT-FOCUSED DRUG DEVELOPMENT WORKSHOP: CHEMOTHERAPY-INDUCED HEARING LOSS
IN PEDIATRIC ONCOLOGY

3:25-3:35 Challenges in Clinical Trial Design in Chemotherapy-Induced Hearing Loss | Greg Aune, MD, PhD, Assistant Professor, UT Health San Antonio-Greehey Children’s Cancer Research Institute

The half-day meeting follows the FDA model for externally-led PFDD meetings and will feature a series of facilitated panel and audience discussions, and a webinar with live polling focused on providing the FDA and other stakeholders with patient views on key issues such as:

Burden of the condition (physical, emotional, financial issues) impacting daily health-related quality of life;

Assessments of current and potential future treatments;

Benefits that patients with chemotherapy-induced hearing loss are looking for in treatments and the risks they are willing to assume in return for more advanced interventions;

Participation in clinical trials and ideas on trial design to make them more appealing to people with chemotherapy-induced hearing loss.